Integration of Behavioral Health by Community Health Workers Into a Lifestyle Intervention That Addresses Reduction of Risk for Cardiovascular Disease in Rural Communities

Prev Chronic Dis. 2026 Oct 8;23:E50. doi: 10.5888/pcd23.260142.ABSTRACTPURPOSE AND OBJECTIVES: Cardiovascular disease (CVD) is the leading cause of death and disability in the US, with higher rates in rural areas. Although community health workers (CHWs) are effective in improving CVD outcomes, limi

S Stephanie Coronel-Mockler

Omega-3 Fatty Acids in the Management of Cardiovascular Disease Prevention

Cardiovasc Drugs Ther. 2026 Oct 8. doi: 10.1007/s10557-026-07974-4. Online ahead of print.ABSTRACTPURPOSE: Omega-3 polyunsaturated fatty acids lower triglycerides and modulate inflammation, thrombosis, and endothelial function, providing a rationale for their use in cardiovascular prevention. This r

S Simone Finocchiaro

Cardiac amyloidosis: what every interventional cardiologist should know

Cardiovasc Interv Ther. 2026 Oct 8. doi: 10.1007/s12928-026-01358-z. Online ahead of print.ABSTRACTCardiac amyloidosis (CA) is increasingly encountered by interventional cardiologists during the evaluation of chest pain, myocardial injury, coronary artery disease, atrial arrhythmias, and aortic sten

Y Yasuhiro Izumiya

The growing burden of myopia in Europe: evidence from population-based cohorts

Eur J Epidemiol. 2026 Oct 8. doi: 10.1007/s10654-026-01435-w. Online ahead of print.ABSTRACTMyopia is a childhood-onset condition driven by excessive axial ocular elongation, associated with increased risk of sight-threatening complications and irreversible visual impairment. Despite rising global p

A Amber Tiemens